Who owns TRISALUS LIFE SCIENCES INC?
- Ticker: TLSI
- CUSIP Number: 89680m101
Tip: Access positions for across all investors
Analyze quarterly positions in Trisalus Life Sciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Trisalus Life Sciences stock
Who bought or sold TRISALUS LIFE SCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| First Light Asset Management | 5.1M | $20M | 100% | Mar 2026 |
|
| AWM Investment Company | 2.1M | $8.3M | 67% | Mar 2026 |
|
| Nantahala Capital Management | 2.1M | $8.3M | 0% | Mar 2026 |
|
| Vanguard Group | 1.5M | $11M | 32% | Dec 2025 |
|
| BlackRock | 1.5M | $6.0M | -2% | Mar 2026 |
|
| Daniel D. Thurber | 1.4M | $5.8M | 100% | Mar 2026 |
|
| Vanguard Capital Management | 1.3M | $5.4M | 100% | Mar 2026 |
|
| Gilder, Gagnon, Howe & Co | 979k | $6.8M | -6% | Dec 2025 |
|
| HPM Partners | 787k | $3.1M | 100% | Mar 2026 |
|
| Geode Capital Management | 777k | $3.1M | 3% | Mar 2026 |
|
| Thompson, Siegel, & Walmsley | 584k | $2.3M | 100% | Mar 2026 |
|
| Kennedy Capital Management | 485k | $1.9M | 100% | Mar 2026 |
|
| Morgan Stanley | 394k | $1.6M | 100% | Mar 2026 |
|
| Empire Financial Management Company | 300k | $1.2M | 317% | Mar 2026 |
|
| State Street Corporation | 265k | $1.8M | 37% | Dec 2025 |
|
| Perkins Capital Management | 230k | $920k | 100% | Mar 2026 |
|
| Northern Trust | 222k | $1.6M | 26% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 218k | $873k | 100% | Mar 2026 |
|
| Bank of America Corporation | 202k | $807k | 100% | Mar 2026 |
|
| Royce & Associates | 200k | $800k | 100% | Mar 2026 |
|
| Vanguard Portfolio Management | 165k | $659k | 100% | Mar 2026 |
|
| White Pine Capital | 164k | $655k | 180% | Mar 2026 |
|
| Charles Schwab Investment Management | 100k | $699k | 75% | Dec 2025 |
|
| CI Private Wealth | 91k | $364k | 100% | Mar 2026 |
|
| UBS Group | 80k | $318k | 1445% | Mar 2026 |
|
| Goldman Sachs Group | 75k | $300k | 14% | Mar 2026 |
|
| CWA Asset Management | 72k | $288k | 0% | Mar 2026 |
|
| Bridgeway Capital Management | 70k | $485k | 0% | Dec 2025 |
|
| Sei Investments | 69k | $276k | 100% | Mar 2026 |
|
| Intrust Bank Na | 66k | $264k | 100% | Mar 2026 |
|
| Bank of New York Mellon | 66k | $263k | 2% | Mar 2026 |
|
| Barclays | 48k | $333k | 80% | Dec 2025 |
|
| MSDC Management | 40k | $160k | 0% | Mar 2026 |
|
| Nuveen | 37k | $146k | 0% | Mar 2026 |
|
| Laird Norton Tyee Trust | 35k | $244k | 100% | Dec 2025 |
|
| HighMark Wealth Management | 33k | $133k | 208% | Mar 2026 |
|
| Deutsche Bank Aktiengesellschaft | 29k | $115k | 22% | Mar 2026 |
|
| Ghisallo Capital Management | 25k | $100k | 100% | Mar 2026 |
|
| Man Group | 23k | $93k | 60% | Mar 2026 |
|
| Connecticut Wealth Management | 22k | $89k | 0% | Mar 2026 |
|
| MetLife Investment Advisors | 18k | $127k | 100% | Dec 2025 |
|
| Cambridge Investment Research Advisors | 16k | $62k | 0% | Mar 2026 |
|
| Vanguard Global Advisers | 15k | $61k | 100% | Mar 2026 |
|
| Rhumbline Advisers | 15k | $60k | -3% | Mar 2026 |
|
| Mirae Asset Global Etfs Holdings | 14k | $58k | 2% | Mar 2026 |
|
| Invesco | 12k | $46k | 12% | Mar 2026 |
|
| Wells Fargo & Company | 12k | $46k | -67% | Mar 2026 |
|
| New York State Common Retirement Fund | 11k | $44k | 0% | Mar 2026 |
|
| FMR | 11k | $75k | 4109% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 5.9k | $24k | -8% | Mar 2026 |
|
| Police & Firemen's Retirement System of New Jersey | 5.4k | $22k | 0% | Mar 2026 |
|
| SRS Capital Advisors | 4.0k | $16k | 0% | Mar 2026 |
|
| Russell Investments | 2.8k | $11k | 3% | Mar 2026 |
|
| Legal & General Group | 2.7k | $11k | -5% | Mar 2026 |
|
| Citigroup | 2.1k | $8.3k | 100% | Mar 2026 |
|
| Tower Research Capital | 1.8k | $12k | -41% | Dec 2025 |
|
| Western Wealth Management | 1.7k | $7.0k | 100% | Mar 2026 |
|
| California State Teachers Retirement System | 1.6k | $6.6k | -12% | Mar 2026 |
|
| Summit Investment Advisors | 1.6k | $6.5k | 0% | Mar 2026 |
|
| Sterling Capital Management | 740.00 | $3.0k | -46% | Mar 2026 |
|
| Hoertkorn Richard Charles | 668.00 | $2.7k | 0% | Mar 2026 |
|
| JDM Financial Group | 530.00 | $2.1k | 100% | Mar 2026 |
|
| Ritter Daniher Financial Advisory LLC / DE | 500.00 | $2.0k | 0% | Mar 2026 |
|
| GAMMA Investing | 386.00 | $1.5k | 566% | Mar 2026 |
|
| Wolverine Asset Management | 346.00 | $1.4k | 100% | Mar 2026 |
|
| Signature | 100.00 | $400.000000 | 0% | Mar 2026 |
|
| CWM | 78.00 | $999.999000 | -13% | Dec 2025 |
|
| Rachor Investment Advisory Services | 51.00 | $204.000000 | 0% | Mar 2026 |
|
| Essential Partners | 43.00 | $172.000000 | 95% | Mar 2026 |
|
| Pnc Financial Services | 35.00 | $140.000000 | 59% | Mar 2026 |
|
| MAI Wealth Advisors | 15.00 | $60.000000 | 100% | Mar 2026 |
|
| Root Financial Partners | 12.00 | $48.000000 | 100% | Mar 2026 |
|
| Caitong International Asset Management | 5.00 | $20.000000 | 100% | Mar 2026 |
|
| EverSource Wealth Advisors | 5.00 | $20.000000 | 100% | Mar 2026 |
|
| Rothschild Investment | 2.00 | $8.000000 | 100% | Mar 2026 |
|
| Sunbelt Securities | 2.00 | $8.000000 | 100% | Mar 2026 |
|
| Farther Finance Advisors | 1.00 | $4.000000 | 100% | Mar 2026 |
|
| True Wealth Design | 1.00 | $4.000000 | 0% | Mar 2026 |
|
Who sold out of Trisalus Life Sciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Wealthcare Advisory Partners | Dec 2025 | 644k | $4.5M |
| Alyeska Investment Group | Dec 2025 | 408k | $2.8M |
| Squarepoint Ops | Dec 2025 | 44k | $310k |
| Millennium Management | Dec 2025 | 36k | $249k |
| Connective Capital Management | Dec 2025 | 33k | $229k |
| Abel Hall | Dec 2025 | 11k | $73k |
| Jpmorgan Chase & Co | Sep 2025 | 7.5k | $35k |
| Amalgamated Bank | Dec 2025 | 956.00 | $7.0k |
| Royal Bank of Canada | Sep 2025 | 351.00 | $2.0k |